CustoMed
Transforming Surgery Excellence with 3D-printed Patient-specific Instruments at Scale
Company Overview
Snapshot
Founded in October 2023, CustoMed operates with 1–10 employees. The company has raised $6M across one funding round from 5 investors. In October 2025, CustoMed announced $6M in funding to scale its AI-powered 3D-printed solutions for orthopedic surgery.
Business overview
CustoMed develops an automation platform that leverages AI-powered segmentation to convert CT scans into detailed 3D anatomical models. This technology provides surgeons with an intuitive interface for fine-tuning surgical plans and patient-specific instrument (PSI) designs, ensuring optimal customization. The platform also offers hospitals an integrated case manager and a comprehensive library of procedures and hardware to streamline case management. CustoMed's solutions are designed to generate computer-optimized PSIs for immediate printing, serving the orthopedic and medical device sectors within the Health Tech & Life Sciences industry.
Strategic signal
In October 2025, CustoMed secured $6M in funding to advance its AI-powered 3D-printed solutions for orthopedic surgery. This investment signals strong market validation for CustoMed's approach to integrating artificial intelligence with patient-specific medical devices, indicating a clear trajectory towards scaling its innovative technology and expanding its impact on surgical excellence.
Log in to access full profile ›Company Intelligence Q&A
- What is CustoMed's core technology?
- CustoMed's core technology is an AI-powered automation platform that converts CT scans into detailed 3D anatomical models, enabling precise surgical planning and the design of patient-specific instruments (PSIs).
- When was CustoMed founded?
- CustoMed was founded in October 2023.
- What was a significant funding event for CustoMed?
- In October 2025, CustoMed announced $6M in funding to scale its AI-powered 3D-printed solutions for orthopedic surgery. Investors included Avishai Abrahami and Flag Capital.
- What industries does CustoMed serve?
- CustoMed primarily serves the Health Tech & Life Sciences sector, with a focus on orthopedic surgery and medical devices, providing solutions for hospitals and surgeons.
- What is the primary benefit of CustoMed's platform for surgeons?
- CustoMed's platform offers surgeons an intuitive interface for precise fine-tuning of surgical plans and patient-specific instrument (PSI) designs, ensuring optimal customization for each patient.